microdosing glp 1 dose GLP-1s: Risks & Considerations What is Microdosing a GLP-1?

However, GLP-1R agonists elicit nausea and vomiting 6,10 , and increase mean heart rate via directly stimulating sinoatrial node and enhancing sympathetic nervous system tone 10,11,12

Those using GLP-1 medications solely for weight management (without diabetes) are not at risk for diabetic retinopathy progression, though they should report any visual symptoms promptly given the ongoing investigation of rare non-retinopathy eye events

It is to use them correctly with adequate protein intake (typically 1.2 to 1.6 grams per kilogram of body weight per day) and a structured resistance exercise program

Among non-users, injection aversion remains a meaningful barrier to uptake